References
- Editorial. Measles encephalitis during immunosuppressive treatment. Br Med J 1976; 1: 1552
- Narayan O, Penney J B, Johnson R T, Herdon R M, Weiner LP. Etiology of progressive multifocal leukoencephalopathy: Identification of papavovirus. N Engl J Med 1973; 289: 1278–1282
- Price R, Chernik N L, Horta Barbosa L, Posner JB. Herpes simplex encephalitis in an anergic patient. Am J Med 1973; 54: 222–228
- Hanley D F, Wolinsky JS. Herpes virus encephalitis in the severely immuno-compromised patient. Ann Neurol 1981; 10: 98, (Abstr.)
- Chou S M, Roos R, Burrell R, Gutmann L, Harley JB. Subactue focal adenovirus encephalitis. J Neuropathol Exp Neurol 1973; 32: 34–50
- Horten B, Price R W, Jimeney D. Multifocal varicella zoster virus leucoencephalitis temporally remote from herpes zoster. Ann Neurol 1981; 9: 251–266
- Dorfman LJ. Cytomegalovirus encephalitis in adults. Neurology 1973; 23: 136–144
- Allen JC. The effects of cancer therapy on the nervous system. J Pediatr 1978; 93: 903–909
- Diven W F, Flew R H, Ihongbe J C, Omene J. CSF lysosomal hydrolase activity as an aid in the diagnosis of bacterial meningitis. Eur J Pediatr 1981; 136: 9–12
- Graeber J E, Stuart MJ. Spinal-fluid procoagulant activity: A sensitive indicator of central-nervous-system damage. Lancet 1978; 2: 285–288
- Murphy J V, Yunis EJ. Encephalopathy following measles infection in children with chronic illness. J Pediatr 1976; 88: 937–942
- Agamanolis D P, Tan J S, Parker DL. Immunosuppressive measles encephalitis in a patient with a renal transplant. Arch Neurol 1979; 36: 686–690
- Smyth D, Tripp J H, Brett E M, Marshall W C, Almeida J, Dayan A D, Coleman J C, Dayton R. Atypical measles encephalitis in leukaemic children in remission. Lancet 1976; 2: 574
- Pullen C R, Noble T C, Scott D J, Wisniewski K, Gardner PS. Atypical measles infections in leukaemic children on immunosuppressive treatment. Br Med J 1976; 1: 1562–1565
- Olding-Stenkvist E, Forsgren M, Henley D, Kreuger A, Lundmark K-M, Nilsson A, Wadell G. Measles encephalopathy during immunosuppression: Failure of interferon treatment. Scand J Infect Dis 1982; 14: 1–4
- Merigan T C, Rand K H, Pollard R B, Abdallah P S, Jordon G W, Fried RP. Human leukocyte interferon for the treatment of herpes zoster in patients with cancer. N Engl J Med 1978; 298: 981–987
- Ruutiainen J, Panelius M, Cantell K. Toxic effects of interferon administered intrathecally. Br Med J 1983; 286: 940